Lee's Pharmaceutical Holdings Limited (HKG:0950)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Licensed-In Products	564.34M	553.24M	467.28M	733.34M	749.14M
Licensed-In Products Growth	2.01%	18.40%	-36.28%	-2.11%	10.50%
Proprietary and Generic Products	871.65M	846.73M	585.76M	499.81M	517.02M
Proprietary and Generic Products Growth	2.94%	44.55%	17.20%	-3.33%	-4.04%
Total	1.44B	1.40B	1.05B	1.23B	1.27B
Total Growth	2.57%	32.95%	-14.61%	-2.61%	4.06%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
The People's Republic of China (The PRC)	1.44B	1.40B	1.05B	1.23B	1.27B
The People's Republic of China (The PRC) Growth	2.57%	32.95%	-14.61%	-2.61%	4.06%
Total	1.44B	1.40B	1.05B	1.23B	1.27B
Total Growth	2.57%	32.95%	-14.61%	-2.61%	4.06%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 9, 2026

Data Sources Report a data error